Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 vif protein

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 494-507

  Karczewski, Mary K ^a   Strebel, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIF PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMEDIATE FILAMENT; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRION; VIRUS GENE; VIRUS INFECTIVITY;

ANIMAL; BASE SEQUENCE; CELL LINE; CYTOSKELETON; DNA, VIRAL; GENE PRODUCTS, VIF; HELA CELLS; HIV SEROPOSITIVITY; HIV-1; HUMAN; MOLECULAR SEQUENCE DATA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; VIMENTIN; VIRION;

EID: 0029655893     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.494-507.1996     Document Type: Article

References (50)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. - HIV-1 mutants in CEM cells suggests that Vif affects late steps of the viral life cycle. Virology 193:186-192.
3. - mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol 69:2058-2067
4. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stephenson. 1993 A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (London) 365:666-669.
5. Chou, Y. H., J. R. Bischoff, D. Beach, and R. D. Goldman. 1990. Intermediate filament reorganization during mitosis is mediated by p34cdc2 phosphorylation of vimentin. Cell 62:1063-1071.
6. - human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
7. Doorbar, J., S. Ely, J. Sterling, C. McLean, and L. Crawford. 1991. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network Nature (London) 352:824-827.
8. Fan, L., and K. Peden. 1992. Cell free transmission of Vif mutants of HIV-1 Virology 190:19-29
9. Fisher, A. G., B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro Science 237:888-893.
10. Fuchs, E., and K. Weber. 1994. Intermediate filaments' structure, dynamics, function, and disease. Annu Rev. Biochem. 63:345-382.
11. - T lymphocytes. J. Virol. 66:6489-6495.
12. Gabuzda, D. H., H. Li, K. Lawrence, B. S. Vasir, K. Crawford, and E. Langhoff. 1994. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages J Acquired Immune Defic. Syndr. 7:908-915.
13. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388
14. Garrett, E. D., L. S. Tiley, and B. R. Cullen. 1991. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products J. Virol. 65:1653-1657.
15. Gerace, L., and B. Burke. 1988. Functional organization of the nuclear envelope. Annu. Rev. Cell Biol. 4:335-374.
16. Goldman, R. D., A. E. Goldman, K. J. Green, J. C. R. Jones, S. M. Jones, and H. Y. Yang. 1986 Intermediate filament networks: organization and possible functions of a diverse group of cytoskeletal elements. J. Cell Sci. Suppl. 5:69-97.
17. Goncalves, J., P. Jallepalli, and D. H. Gabuzda. 1994. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J Virol 68:704-712.
18. Goncalves, J., B. Shi, X. Yang, and D. H. Gabuzda. 1995 Biological activity of human immunodeficiency type 1 Vif requires membrane targeting by C-terminal basic domains. J. Virol. 69:7195-7204.
19. Gorman, C. M., G. T. Merlino, M. C. Willingham, I. Pastan, and B. H. Howard. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci USA 79:6777-6781.
20. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
21. Guy, B., M. Geist, K. Dott, D. Spehner, M. P. Kieny, and J. P. Lecocq. 1991. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J. Virol. 65:1325-1331.
22. Heinzinger, N. K., M. I. Bukrinskj, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
23. Hoeglund, S., A. Oehagen, K. Lawrence, and D. Gabuzda. 1994. Rule of vif during packaging of the core of HIV-1. Virology 201:349-355
24. Hoener, B., R. L. Shoeman, and P. Traub. 1991. Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture. J. Cell Sci 100:799-807.
25. Kishi, M., Y. Nishino, M. Sumiya, K. Ohki, T. Kimura, T. Goto, M. Nakai, M. Kakinuma, and K. Ikuta. 1992. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. J. Gen. Virol. 73:77-87.
26. Klymkowsky, M. W. 1981. Intermediate filaments in 3T3 cells collapse alter intracellular injection of a monoclonal anti-intermediate filament antibody Nature (London) 291:249-251.
27. Klymkowsky, M. W., J. B. Bachant, and A. Domingo. 1989 Functions of intermediate filaments. Cell Motil. Cytoskel. 14:309-331.
28. Lin, J. J. C., and J. R. Feramisco. 1981. Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody Cell 24:185-193
29. Liu, H., X. Wu, M. Newman, G. M. Shaw, B. H. Hahn, and J. C. Kappes. 1995. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:7630-7638.
30. Ma, X., K. Sakai, K. Sinangil, E. Golub, and D. J. Volsky. 1990. Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells' efficient virus entry followed by delayed expression of its RNA and protein. Virology 176:184-194.
31. Maldarelli, F., M. V. Chen, R. L. Willey, and K. Strebel. 1993 Human immunodeficiency virus type 1 Vpu protein is an oligomeric type 1 integral membrane protein. J Virol. 67:5056-5061.
32. Michaels, F. H., N. Hattori, R. C. Gallo, and G. Franchini. 1993. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Res Hum. Retroviruses 9:1025-1030.
33. Oberste, M. S., and M. A. Gonda. 1992. Conservation of ammo-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6:95-102.
34. Reddy, T. R., G. Kraus, O. Yamada, D. J. Looney, M. Suhasini, and F. Wong-Staal. 1995. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 vif mutants. J. Virol. 69:3549-3553.
35. Sakai, H., R. Shibata, J. I. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1666.
36. Sarria, A. J., S. K. Nordeen, and R. M. Evans. 1990. Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network. J. Cell Biol. 111:553-565.
37. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
38. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1991. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 183:677-686.
39. Shoeman, R. L., B. Hoener, T. J. Stoller, C. Kesselmeier, M. C. Miedel, P. Traub, and M. C. Graves. 1990. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc. Natl. Acad. Sci. USA 87:6336-6340.
40. Simon, J. H. M., T. E. Southerling, J. C. Peterson, B. E. Meyer, and M. H. Malim. 1995. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69:4166-4172
41. Soellner, P., R. A. Quinlan, and W. W. Franke. 1985. Identification of a distinct soluble subunit of an intermediate filament protein: tetrameric vimentin from living cells. Proc. Natl. Acad. Sci. USA 82:7929-7933.
42. Sommers, C. L., S. E. Heckford, J. M. Skerker, P. Worland, J. A. Torri, E. W. Thompson, S. W. Byers, and E. P. Gelmann. 1992. Loss of epithelial markers and acquisition of vimentin expression in adnamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res. 52:5190-5197.
43. Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
44. Stappenbeck, T. S., and K. J. Green. 1992. The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J. Cell Biol. 116:1197-1209.
45. Steinert, P. M., and D. R. Roop. 1988. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 57:593-625.
46. Strebel, K. Unpublished data.
47. Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature (London) 328:728-730.
48. vonSchwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91:6992-6996.
49. vonSchwedler, U., J. Song, C. Aiken, and D. Trono. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
50. White, E., and R. Cipriani. 1989. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc Natl. Acad. Sci. USA 86:9886-9890.